In BCN, EGF-EGFR pair was identified as the key regulator (EGF interactions = 152, EGFR interactions = 358, total number of interactions = 510), which has been known to be associated with poor prognosis in breast cancer (16). The gene discussed is EGF; the disease is breast carcinoma.